Sunbelt Securities »

Lineage Cell Therapeutics In shares owned by Sunbelt Securities

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Sunbelt Securities from 13F filings

Historical chart of Sunbelt Securities investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Sunbelt Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Sunbelt Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.2k 2.0k 1.58
2019-12-31 $994 4.5k 0.22

More positions owned by Sunbelt Securities

Exxon Mobil Corp Stock (XOM)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Broadcom Stock (AVGO)
Ishares Gold Trust Etf (IAU)
Invesco Qqq Trust Series I Etf (QQQ)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares Core S&p 500 Etf Etf (IVV)
Bluerock Pvt Real Estate Cef (BPRE)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Amazon Stock (AMZN)
Innovator Defined Wealth Shield Etf Etf (BALT)
Schwab U.s. Large-cap Value Etf Etf (SCHV)

View all positions for Sunbelt Securities

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Vanguard Capital Management
Defender Capital
Millennium Management
Raffles Associates
Fifth Third Bancorp
Brian McDonald
BlackRock
Armistice Capital
Geode Capital Management
Renaissance Technologies
Morgan Stanley
UBS Group
Marshall Wace

View all funds holding Lineage Cell Therapeutics In